Yi, Yong Weon <br/><br/>
Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6.  [electronic resource] 

 -  International journal of oncology  Jul 2015 
 - 122-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2015.2982  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Down-Regulation<br/>Drug Synergism<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gefitinib<br/>Humans<br/>Indoles--pharmacology<br/>Peptide Library<br/>Piperazines--pharmacology<br/>Proto-Oncogene Proteins c-met--antagonists & inhibitors<br/>Quinazolines--pharmacology<br/>Ribosomal Protein S6--metabolism<br/>Sulfonamides--pharmacology<br/>Triple Negative Breast Neoplasms--drug therapy